Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06975202

Test-retest Reliability and Agreement of Trunk Muscle Activation in Pain-free Persons

The aim of the study is to investigate test-retest reliability and agreement of trunk muscle activation during functional tasks and clinical sensorimotor control tests in pain-free persons.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Faculty of Medicine and Health Sciences

Ghent, 9000, Belgium

Location status: Recruiting

Location contact

Hannes Meirezonne, MSc

SUB_INVESTIGATOR

Lieven Danneels, Professor

CONTACT

[email protected]

+32 9 332 26 35

Michiel Brandt, MSc

SUB_INVESTIGATOR

Thomas Matheve, Professor

CONTACT

[email protected]

About this study

Optimal muscle function is essential for daily life functioning. The current literature suggests that alterations in trunk muscle activation might be one of the contributing factors to the persistence and recurrence of musculoskeletal disorders, including low back pain and lower limb injuries. It is crucial that trunk muscle activation during functional tasks has sufficient reliability and agreement to interpret (longitudinal) studies.

A limited number of studies have investigated the reliability and agreement of trunk muscle activation during dynamic (functional) tasks. Moreover, all these studies used simple discrete outcomes such as mean or peak amplitude. An important limitation is that these single zero-dimensional outcome values ignore the temporal aspects of dynamic tasks. As such, potentially relevant time-specific characteristics of muscle activation might be missed. A comprehensive reliability analysis of curve data (i.e., one-dimensional data) that considers the temporal timeframe is therefore required. An overview of reliability analyses of curve data can be found in Pini et al. This paper concluded that integrated pointwise indices can be recommended. Recently, this innovative analysis was used in biomechanical studies investigating the kinematics and kinetics during jump landing. However, to the best of our knowledge, integrated pointwise indices have not been used to determine reliability and agreement of muscle activation during functional tasks.

The lumbar multifidus has received extensive attention over the past 25 years. The multifidus muscle consists of deep and short fibers that overlay up to 2 segments (i.e., deep multifidus) and more superficial and longer fibers that cross up to 5 segments (i.e., superficial multifidus). As a result of their anatomy, the deep multifidus (DM) predominantly provides segmental stabilization through compressive forces, while the superficial multifidus (SM) mainly generate lumbar movement (i.e., extension, lateral bending, and rotation). Previous studies showed that the distinction between DM and SM activation is especially important for persons with low back pain. Although the results in persons with low back pain vary, the current literature shows a trend towards an overall reduced activation of the DM, while the activation of the SM is often augmented. As such, a clinical test that assesses voluntary DM activation has been proposed and specific motor control therapy that targets the DM has been shown to reduce pain and disability in patients with low back pain. Fine-wire electromyography (EMG) is the only technique that is able to record selective deep muscle activation during dynamic functional tasks, as opposed to other techniques such as surface EMG. However, reliability studies that use fine-wire EMG to measure selective DM and SM activation during functional tasks are currently lacking.

Therefore, this study aims to investigate test-retest reliability and agreement of trunk muscle activation measured with surface and fine-wire EMG during functional tasks in pain-free persons.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pain-free persons between 18 and 65 years old

Exclusion criteria

  • Persons experiencing low back pain in the past year
  • Patients with serious underlying conditions (e.g., multiple sclerosis)
  • Previous spinal surgery
  • Persons with any type of blood clotting disorder
  • Persons with upper-limb complaints that prevent them from exerting (maximum) force with their arms or hands.

Treatment and study plan

No intervention

Other

No intervention

Primary outcomes

  1. Trunk muscle onset during the rapid arm movement test

    Time frame: Baseline (test-session)

    Trunk muscle onset latencies in response to the unilateral rapid arm movement test will be measured by means of electromyography.

  2. Trunk muscle onset during the rapid arm movement test

    Time frame: After a 30-minute break (retest-session)

    Trunk muscle onset latencies in response to the unilateral rapid arm movement test will be measured by means of electromyography.

Secondary outcomes

  1. Trunk muscle (co-)activation

    Time frame: Baseline (test-session)

    The participant sits on a stool and holds a horizontal bar with both hands, shoulders at 90 degrees (arms are horizontal). The horizontal bar is secured to the ground using a rope and weights. The participant pushes the horizontal bar upwards without moving the arms, pelvis, or spine. The activation of the back and abdominal muscles will be further investigated.

  2. Trunk muscle (co-)activation

    Time frame: After a 30-minute break (retest-session)

    The participant sits on a stool and holds a horizontal bar with both hands, shoulders at 90 degrees (arms are horizontal). The horizontal bar is secured to the ground using a rope and weights. The participant pushes the horizontal bar upwards without moving the arms, pelvis, or spine. The activation of the back and abdominal muscles will be further investigated.

  3. Back muscle activation

    Time frame: Baseline (test-session)

    Back muscle activation will be analyzed during (1) bilateral reaching in standing position, (2) unilateral/bilateral reaching starting in neutral sitting position, and (3) unilateral/bilateral reaching starting in habitual sitting position.

  4. Back muscle activation

    Time frame: After a 30-minute break (retest-session)

    Back muscle activation will be analyzed during (1) bilateral reaching in standing position, (2) unilateral/bilateral reaching starting in neutral sitting position, and (3) unilateral/bilateral reaching starting in habitual sitting position.

  5. Voluntary multifidus activation

    Time frame: Baseline (test-session)

    Voluntary multifidus activation will be measured while the participant lies prone on a treatment table. The participant will be instructed to gently activate the multifidus muscle without movement of the pelvis or spine, while breathing is maintained.

  6. Voluntary multifidus activation

    Time frame: After a 30-minute break (retest-session)

    Voluntary multifidus activation will be measured while the participant lies prone on a treatment table. The participant will be instructed to gently activate the multifidus muscle without movement of the pelvis or spine, while breathing is maintained.

  7. Involuntary multifidus activation

    Time frame: Baseline (test-session)

    Involuntary multifidus activation will be assessed by means of the multifidus lift test (Hebert et al., 2015). The participant is lying in the prone position with the shoulders in 120° abduction and 90° flexion at the elbows. The participant will be asked to lift the entire arm approximately 5 cm from the treatment table. The multifidus activation on the contralateral side will be investigated further.

  8. Involuntary multifidus activation

    Time frame: After a 30-minute break (retest-session)

    Involuntary multifidus activation will be assessed by means of the multifidus lift test (Hebert et al., 2015). The participant is lying in the prone position with the shoulders in 120° abduction and 90° flexion at the elbows. The participant will be asked to lift the entire arm approximately 5 cm from the treatment table. The multifidus activation on the contralateral side will be investigated further.

Study contacts

Contact information is provided by the study sponsor or research team.

Lieven Danneels, Professor

CONTACT

[email protected]

+32 9 332 26 35

Thomas Matheve, Professor

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

University Ghent

Other

Collaborators

  • VZW Educatieve Lichaamsbeweging

Registry information

Acronym: MAS-Reliab

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
May 16, 2025
Registry last updated
May 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.